The effects are supported by the compound's ability to regulate a variety of oncogenic and tumor‐suppressive signaling pathways, particularly PI3K/Akt, STAT3, NF‐kB, MAPK, AMPK, and Wnt/beta‐catenin. The gene discussed is CTNNB1; the disease is neoplasm.